Bluejay Diagnostics, Inc. Balance Sheet
BJDX|2 years of annual SEC 10-K data (FY2022-FY2023)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$5M
FY2023
Cash
$2M
Cash and equivalents
Total Debt
N/A
FY2023
Shareholder Equity
$3M
FY2023
Bluejay Diagnostics, Inc. had $5M in total assets and $3M in shareholders' equity as of FY2023.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -10.44 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -343.8% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 |
|---|---|---|
| Cash & Equivalents | $2.2M | $10.1M |
| Current Assets | $3.2M | $11.8M |
| PP&E (Net) | $1.3M | $1.2M |
| Total Assets | $4.9M | $13.5M |
| Current Liabilities | $1.8M | $1.6M |
| Shareholders' Equity | $2.9M | $11.5M |